title: Lipid- and polymer-based nanostructures for cancer theranostics.
abstract: The relatively new field of nanotheranostics combines the advantages of in vivo diagnosis with the ability to administer treatment through a single nano-sized carrier, offering new opportunities for cancer diagnosis and therapy. Nanotheranostics has facilitated the development of nanomedicine through direct visualization of drug blood circulation and biodistribution. From a clinical perspective, nanotheranostics allows therapies to be administered and monitored in real time, thus decreasing the potential of under- or over-dosing and allowing for more personalized treatment regimens. Herein, we review recent development of nanotheranostics using lipid- and polymer-based formulations, with a particular focus on their applications in cancer research. Recent advances in nanotechnology aimed to combine therapeutic molecules with imaging agents for magnetic resonance imaging, radionuclide imaging, or fluorescence imaging are discussed.
authors: Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.
authors: Brian T
authors: BT
authors: Luk
authors: Ronnie H
authors: RH
authors: Fang
authors: Liangfang
authors: L
authors: Zhang
mesh_terms: D000818:Animals; D006801:Humans; D008055:Lipids / Q000627:therapeutic use*; D008081:Liposomes / Q000737:chemistry; D049329:Nanostructures / Q000627:therapeutic use*; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D011108:Polymers / Q000627:therapeutic use
chemical_list: D008055:Lipids; D008081:Liposomes; D011108:Polymers
keywords: fluorescence imaging; liposomes; magnetic resonance imaging; nanotheranostics; polymeric nanoparticles; radionuclide imaging
references: Mol Pharm. 2010 Dec 6;7(6):1899-912
references: 20822168
references: Int J Nucl Med Biol. 1979;6(2):75-83
references: 113357
references: Bioconjug Chem. 1997 Sep-Oct;8(5):649-57
references: 9327127
references: Nat Rev Drug Discov. 2008 Jul;7(7):591-607
references: 18591980
references: Mol Pharm. 2006 Sep-Oct;3(5):507-15
references: 17009849
references: Biomaterials. 2012 Mar;33(8):2521-31
references: 22204981
references: Adv Drug Deliv Rev. 2008 Dec 14;60(15):1650-62
references: 18848591
references: Biomaterials. 2011 Jun;32(17):4151-60
references: 21367450
references: Nucl Med Commun. 2008 Mar;29(3):193-207
references: 18349789
references: Ann Nucl Med. 1998 Apr;12(2):61-70
references: 9637275
references: Nanomedicine. 2010 Dec;6(6):797-807
references: 20599526
references: Nat Rev Clin Oncol. 2011 Apr 26;8(9):517-27
references: 21522122
references: J Control Release. 2009 Feb 20;134(1):55-61
references: 19038299
references: Mol Pharm. 2010 Dec 6;7(6):1879
references: 21128687
references: Biomaterials. 2011 Sep;32(27):6570-8
references: 21641639
references: Nat Rev Cancer. 2002 Sep;2(9):683-93
references: 12209157
references: Nat Nanotechnol. 2007 Dec;2(12):751-60
references: 18654426
references: Bioconjug Chem. 2011 Oct 19;22(10):1879-903
references: 21830812
references: Eur Radiol. 2001;11(11):2319-31
references: 11702180
references: Clin Cancer Res. 2001 Feb;7(2):243-54
references: 11234875
references: Nat Rev Drug Discov. 2011 Oct 21;10(11):835-52
references: 22015921
references: Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):10901-6
references: 15256592
references: J Biol Inorg Chem. 2004 Sep;9(6):706-12
references: 15232722
references: J Nucl Med. 2009 Nov;50(11):1743-6
references: 19837751
references: Biomaterials. 2012 Feb;33(6):1827-37
references: 22142770
references: Chem Rev. 2010 May 12;110(5):2620-40
references: 20000749
references: J Nucl Med. 2004 Oct;45(10):1776-83
references: 15471848
references: Magn Reson Med. 2004 Jun;51(6):1153-62
references: 15170835
references: Nano Lett. 2006 Nov;6(11):2427-30
references: 17090068
references: Nat Rev Drug Discov. 2008 Sep;7(9):771-82
references: 18758474
references: Biomaterials. 2011 Mar;32(9):2334-41
references: 21216003
references: Oncology (Williston Park). 2007 Nov;21(12):1503-8; discussion 1511, 1513, 1516 passim
references: 18077994
references: Ann Oncol. 2000 Aug;11(8):1029-33
references: 11038041
references: ACS Nano. 2011 Jul 26;5(7):5594-607
references: 21671580
references: Nucl Med Biol. 2009 Jul;36(5):515-24
references: 19520292
references: Nanomedicine (Lond). 2008 Apr;3(2):137-40
references: 18373419
references: Magn Reson Med. 1991 Jun;19(2):406-15
references: 1881329
references: Trends Pharmacol Sci. 2009 Nov;30(11):592-9
references: 19837467
references: Clin Pharmacol Ther. 2008 May;83(5):761-9
references: 17957183
references: Mol Pharm. 2011 Aug 1;8(4):1401-7
references: 21696189
references: J Control Release. 2011 May 30;152(1):21-9
references: 21457740
references: Int J Pharm. 2011 Sep 20;416(2):443-7
references: 21315141
references: Mol Pharm. 2009 Mar-Apr;6(2):520-30
references: 19718803
references: Nanotechnology. 2009 Apr 1;20(13):135101
references: 19420485
references: Angew Chem Int Ed Engl. 2008;47(38):7284-8
references: 18696519
references: Anticancer Drugs. 2005 Aug;16(7):691-707
references: 16027517
references: Nucl Med Biol. 2008 Nov;35(8):883-93
references: 19026950
references: Biomacromolecules. 2008 Jan;9(1):36-42
references: 18047289
references: FEBS Lett. 1989 Dec 4;258(2):343-5
references: 2599097
references: Anticancer Res. 2000 Sep-Oct;20(5A):3339-45
references: 11062762
references: Annu Rev Med. 2012;63:185-98
references: 21888516
references: Exp Neurol. 2005 Dec;196(2):381-9
references: 16197944
references: Adv Drug Deliv Rev. 2010 Feb 17;62(2):246-57
references: 20060431
references: Nat Rev Drug Discov. 2010 Aug;9(8):615-27
references: 20616808
references: J Control Release. 2011 Feb 28;150(1):117-24
references: 21075152
references: Nat Rev Cancer. 2005 Mar;5(3):161-71
references: 15738981
references: ACS Nano. 2009 Jan 27;3(1):16-20
references: 19206243
references: Biomaterials. 2007 Feb;28(5):869-76
references: 17055572
references: Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19347-52
references: 22087004
references: J Am Chem Soc. 2005 Aug 3;127(30):10676-85
references: 16045355
references: J Nucl Med. 2003 Dec;44(12):1992-9
references: 14660726
references: Biomaterials. 2011 Feb;32(5):1387-95
references: 21093041
references: FASEB J. 2005 Dec;19(14):2008-10
references: 16204353
references: Adv Mater. 2011 Sep 22;23(36):H217-47
references: 21842473
references: Nat Biotechnol. 1999 Apr;17(4):375-8
references: 10207887
references: Phys Med Biol. 1996 Oct;41(10):1905-14
references: 8912370
references: Nat Nanotechnol. 2011 Jan;6(1):13-22
references: 21151110
references: Mol Pharm. 2006 Sep-Oct;3(5):525-30
references: 17009851
references: Mol Pharm. 2010 Feb 1;7(1):32-40
references: 19708690